相关实验视频

Updated: Sep 16, 2025

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

通过WTAP介导的m6一种修饰通过调节前列腺癌中的NR3C1促进药物敏感性

Huifeng Wang^1,2, Die Zhang³, Yiqiang Ouyang⁴

¹Department of Human Anatomy, School of Basic Medical Sciences, Guangxi Medical University, Nanning, 530021, China.

Science China. Life sciences

|July 12, 2025

概括

威尔姆斯威尔姆斯是什么意思

科学领域:

在瘤学瘤学.
分子生物学分子生物学
表观遗传学在表观遗传学中,表观遗传学是指表观遗传学.

背景情况:

人们还没有完全理解割抵抗性前列腺癌 (CRPC) 的机制.
N6-甲基氨酸 (m6A) 是一种表观遗传修饰,在CRPC中没有明确的作用.
威尔姆斯瘤1和酸盐激酶M2样蛋白 (WTAP) 是一个关键的m6A调节器.

研究的目的:

研究WTAP和m6A在CRPC发育和胺胺药物敏感性中的作用.
阐明CRPC中涉及WTAP,YTHDF2和NR3C1的分子机制.
确定WTAP/YTHDF2/NR3C1轴在前列腺癌中的临床相关性.

主要方法:

在CRPC组织中分析了WTAP表达.
进行了体外和体内实验来研究WTAP/YTHDF2/NR3C1轴.
评估了WTAP,YTHDF2,NR3C1表达和临床结果之间的相关性.

主要成果:

在CRPC中,WTAP被下调,低表达预测了生存率低下.
过度表达WTAP增强了CRPC细胞中的胺胺药物敏感性.
确定WTAP/YTHDF2/NR3C1轴是CRPC恶性瘤和药物敏感性的关键调节器.
在前列腺癌组织中,WTAP,YTHDF2和NR3C1的表达与临床相关.

结论:

在CRPC中,WTAP起到关键的调节作用,影响恶性瘤和胺胺敏感性.
通过m6A介导的WTAP/YTHDF2/NR3C1轴在CRPC中是一个新的机制.
在CRPC中,WTAP显示出作为预后标记物和治疗点的潜力,用于改善胺胺药物敏感性.

关键词:

在NR3C1中,它是NR3C1.在WTAP中,使用的是WTAP.这就是YTHDF2的原因.在CRPC中使用CRPC.药物敏感性药物敏感性 m6A 一个很好的.

更多相关视频

Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry

Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry

Published on: April 21, 2022

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...

Master Transcription Regulators

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...